These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 13985698)

  • 1. [Therapy of erysipelas with 2-sulfanilamido-3-methoxypyrazine].
    POSTIGLIONE F; D'AVINO M
    Chemotherapia (Basel); 1963; 6():267-72. PubMed ID: 13985698
    [No Abstract]   [Full Text] [Related]  

  • 2. 2-Sulfanilamido-3-methoxypyrazine: a new long-action sulfonamide.
    CESANA A; VENTURA R
    Panminerva Med; 1962 Apr; 4():184-7. PubMed ID: 13877775
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy of penicillin and 2-sulfanilamido-5-methyl-1,3,4, thiodiazole (lucosil) in the treatment of erysipelas.
    MORTENSEN O
    Acta Med Scand; 1951; 139(6):465-71. PubMed ID: 14837702
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of a sulfonamide (3-sulfanilamido-6-methoxypyridazine) on the serum level of properdin].
    GRECO M; COLALONGO G
    Boll Soc Ital Biol Sper; 1961 Apr; 37():296-8. PubMed ID: 13708145
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the treatment of erythema elevatum diutinum with 3-sulfanilamido-6-methoxypyridazine (lederkyn)].
    KALKOFF KW
    Dermatol Wochenschr; 1960 Jul; 142():788-800. PubMed ID: 13750928
    [No Abstract]   [Full Text] [Related]  

  • 6. Erysipelas of the upper extremity following locoregional therapy for breast cancer.
    El Saghir NS; Otrock ZK; Bizri AR; Uwaydah MM; Oghlakian GO
    Breast; 2005 Oct; 14(5):347-51. PubMed ID: 15990307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [2-Sulfanilamido-3-methoxypyrazine in the treatment of various inflammatory forms of the female genital tract].
    DE CECCO L
    Clin Ter; 1963 Mar; 24():543-51. PubMed ID: 14025743
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-statistical investigations on the therapy of erysipelas].
    RONDANELLI EG; GORINI P; FIORI GP
    Sem Med; 1962 Oct; 121():1597-606. PubMed ID: 13982679
    [No Abstract]   [Full Text] [Related]  

  • 9. Wrong diagnosis erysipelas: hypodermitis - case series and review of literature.
    Reich-Schupke S; Kreuter A; Altmeyer P; Stücker M
    J Dtsch Dermatol Ges; 2009 Mar; 7(3):222-5. PubMed ID: 18783427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blistering erysipelas: not a rare entity.
    Chong FY; Thirumoorthy T
    Singapore Med J; 2008 Oct; 49(10):809-13. PubMed ID: 18946616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wound healing of chronic leg ulcers under the influence of erysipelas.
    Trebing D; Göring HD
    Eur J Dermatol; 2004; 14(1):56-7. PubMed ID: 14965798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study.
    Vignes S; Dupuy A
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):818-22. PubMed ID: 16898904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subclinical erysipelas and its significance for epidemiology of erysipelas].
    WELLMANN G
    Zentralbl Bakteriol Orig; 1955; 162(4-5):265-74. PubMed ID: 14387151
    [No Abstract]   [Full Text] [Related]  

  • 14. [Erysipelas after osteoarticular prosthesis].
    Dhrif AS; El Euch D; Ben Tekaya N; Mokni M; Cherif F; Azaiz MI; Dhahri AB
    Med Mal Infect; 2005 Sep; 35(9):463-5. PubMed ID: 16271839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic corticosteroids and their place in the management of hemorrhagic erysipelas].
    Ezzine Sebai N; Hicheri J; Trojjet S; Khaled A; Badri T; Zeglaoui F; Fezaa B; Ridha Kamoun M
    Tunis Med; 2008 Jan; 86(1):49-52. PubMed ID: 19472700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Roentgen therapy of chronic recurrent erysipelas].
    FUCHS G; HOFBAUER J
    Wien Med Wochenschr; 1961 Mar; 111():196-8. PubMed ID: 13702363
    [No Abstract]   [Full Text] [Related]  

  • 17. [Erysipelas as the cause of lymphedema].
    Kosenkov AN; Narenkov VM; Abramov IuA
    Khirurgiia (Mosk); 2005; (11):51-3. PubMed ID: 16352995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mitigated erysipelas after implantation of foreign material].
    Sauer J; Weyer T; Seifert A
    Zentralbl Chir; 2004 Jun; 129(3):220-4. PubMed ID: 15237331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erysipelas. Retrospective study of 647 patients].
    Zaraa I; Zeglaoui F; Zouari B; Ezzine N; Fazaa B; Kamoun MR
    Tunis Med; 2004 Nov; 82(11):990-5. PubMed ID: 15822466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and comorbidity of erysipelas in primary care.
    Bartholomeeusen S; Vandenbroucke J; Truyers C; Buntinx F
    Dermatology; 2007; 215(2):118-22. PubMed ID: 17684373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.